Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Yulia Mikhailova"'
Autor:
Yulia Mikhailova, Anna Pozdeeva, Alina Suleimanova, Alexey Leukhin, Alexander Toschev, Timur Lukmanov, Elsa Fatyhova, Evgeni Magid, Igor Lavrov, Max Talanov
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
The effect of inhibitory management is usually underestimated in artificial control systems, using biological analogy. According to our hypothesis, the muscle hypertonus could be effectively compensated via stimulation by bio-plausible patterns. We p
Externí odkaz:
https://doaj.org/article/08f31aa5e83842449957f59144b6b75f
Autor:
Anastasia Ushtanit, Yulia Mikhailova, Ludmila Krylova, Dmitry Grigorash, Marina Makarova, Svetlana Safonova, Danila Zimenkov
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 590 (2023)
The emergence of drug-resistant tuberculosis forced the development of new drugs and the screening of more effective or less toxic analogues. Mycolic acid biosynthesis is targeted by several antituberculosis drugs, isoniazid being one of the most imp
Externí odkaz:
https://doaj.org/article/ec5192df39e140eba8651cb7507b533b
Autor:
Anastasia Ushtanit, Elena Kulagina, Yulia Mikhailova, Marina Makarova, Svetlana Safonova, Danila Zimenkov
Publikováno v:
Antibiotics, Vol 11, Iss 2, p 133 (2022)
Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide
Externí odkaz:
https://doaj.org/article/159dc77db5e2450bb2bf3edfb9a23007
Autor:
Anastasia Ushtanit, Yulia Mikhailova, Alexandra Lyubimova, Marina Makarova, Svetlana Safonova, Alexey Filippov, Sergey Borisov, Danila Zimenkov
Publikováno v:
Antibiotics, Vol 10, Iss 10, p 1243 (2021)
Background: Linezolid, bedaquiline, and newer fluoroquinolones are currently placed as priority Group A drugs for the treatment of drug-resistant tuberculosis. The number of reported linezolid-resistant clinical strains is still low, and the correlat
Externí odkaz:
https://doaj.org/article/02399d81e1c947959e4d6ba49c8d09fd
Autor:
Yulia Mikhailova
This book intertwines two themes in medieval studies hitherto kept apart: comparisons of Latin and Orthodox Europe and the'feudal revolution'of the late- and post-Carolingian periods. The book broadens the debate by comparing texts written in'learned
Autor:
Yulia Mikhailova, M. William Steele
This volume recognizes the growing awareness of the importance of images in international relations, exploring the phenomenon over three centuries as it relates to Russia and Japan. The general perception of one country by another – the ‘stereoty
Autor:
Yulia Mikhailova, Anna Pozdeeva, Alina Suleimanova, Alexey Leukhin, Alexander Toschev, Timur Lukmanov, Elsa Fatykhova, Evgeni Magid, Igor Lavrov, Max Talanov
The inhibitory management effect is usually un- derestimated in artificial control systems, using biological anal- ogy. According to our hypothesis, the muscle hypertonus could be effectively compensated via stimulation by bio plausible patterns. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d67ddb013d2cb14b5bf3e37528aba6aa
https://doi.org/10.21203/rs.3.rs-1661671/v1
https://doi.org/10.21203/rs.3.rs-1661671/v1
Autor:
Yulia Mikhailova
Publikováno v:
ISTORIYA. 13
The study of the history of small countries is one of the research activities of the Institute of World History of the Russian Academy of Sciences. It has its own specific features and fits into the general outline of the global historical process. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d1dfa8bbb5880de991c2697c864c43c
https://doi.org/10.18254/s207987840023576-2
https://doi.org/10.18254/s207987840023576-2
Autor:
Anastasia, Ushtanit, Elena, Kulagina, Yulia, Mikhailova, Marina, Makarova, Svetlana, Safonova, Danila, Zimenkov
Publikováno v:
Antibiotics (Basel, Switzerland). 11(2)
Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9215c9aa86da3e7592bb8232dbe6123e
https://pubmed.ncbi.nlm.nih.gov/35203736
https://pubmed.ncbi.nlm.nih.gov/35203736
Autor:
Alexandra Lyubimova, Svetlana Safonova, Yulia Mikhailova, Alexey Filippov, Sergey Borisov, Danila Vadimovich Zimenkov, Anastasia Ushtanit, Marina N. Makarova
Publikováno v:
Antibiotics
Volume 10
Issue 10
Antibiotics, Vol 10, Iss 1243, p 1243 (2021)
Volume 10
Issue 10
Antibiotics, Vol 10, Iss 1243, p 1243 (2021)
Background: Linezolid, bedaquiline, and newer fluoroquinolones are currently placed as priority Group A drugs for the treatment of drug-resistant tuberculosis. The number of reported linezolid-resistant clinical strains is still low, and the correlat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d4b5be119be3f5c3cc0907207d5d68b